Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kaoru Ogura

Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer

Annals of Cancer Research and Therapy

English

Changes of Hepatic Volume After Successful Kasai Operation.

Tohoku Journal of Experimental Medicine

English

Related publications

Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer

English

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

New England Journal of Medicine

Medicine

2006

English

Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)

Scientific Reports

Multidisciplinary

2019

English

Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

Journal of Cellular Physiology

Clinical Biochemistry

Cell Biology

Physiology

2016

English

Primary Systemic Therapy of Breast Cancer

English

Primary Systemic Therapy for Operable Breast Cancer

British Journal of Cancer

Cancer Research

Oncology

1991

English

Neoadjuvant Chemotherapy of Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy ( 'CEX' Therapy) for HER-2 Negative Breast Cancer, as Retrospective Study in Our Institute

Journal of Nippon Medical School

Medicine

2019

English

A Randomized Phase III Trial of Neoadjuvant Recombinant Human Endostatin, Docetaxel and Epirubicin as First-Line Therapy for Patients With Breast Cancer (CBCRT01)

International Journal of Cancer

Cancer Research

Oncology

2017

English

P2-033Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Dose Dense in Stage III Breast Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kaoru Ogura

Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer

Changes of Hepatic Volume After Successful Kasai Operation.

Related publications

Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)

Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

Primary Systemic Therapy of Breast Cancer

Primary Systemic Therapy for Operable Breast Cancer

Neoadjuvant Chemotherapy of Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy ( 'CEX' Therapy) for HER-2 Negative Breast Cancer, as Retrospective Study in Our Institute

A Randomized Phase III Trial of Neoadjuvant Recombinant Human Endostatin, Docetaxel and Epirubicin as First-Line Therapy for Patients With Breast Cancer (CBCRT01)

P2-033Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Dose Dense in Stage III Breast Cancer